You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RR

Showing 1 - 25 of 7,045
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Drug Resistant Tuberculosis Trial (Nurse-Led Treatment in Primary Care)

Not yet recruiting
  • Drug Resistant Tuberculosis
  • Nurse-Led Treatment in Primary Care
  • (no location specified)
Dec 20, 2022

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia, in Relapse
  • anti Tim-3/CD123 CAR-T cell therapy
  • Xuzhou, Jiangsu, China
    Kailin Xu
Nov 4, 2023

Paroxysmal Atrial Fibrillation Trial in Tel Aviv (Neuromodulation with RR2 device, Mock sham neuromodulation with sham RR2

Recruiting
  • Paroxysmal Atrial Fibrillation
  • Neuromodulation with RR2 device
  • Mock sham neuromodulation with sham RR2 device
  • Tel Aviv, Israel
  • +1 more
May 14, 2023

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti-siglec-6 CAR-T cell therapy)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia, in Relapse
  • anti-siglec-6 CAR-T cell therapy
  • Xuzhou, Jiangsu, China
    Kailin Xu
Aug 2, 2022

Rifampicin-resistant Tuberculosis Trial in Beijing (Sudapyridine, Bedaquiline)

Enrolling by invitation
  • Rifampicin-resistant Tuberculosis
  • Beijing, Beijing, China
    Beijing Chest Hospital affiliated to Capital Medical University
Apr 21, 2023

Maltreatment by Parent Trial in Cleveland, Columbus, Pittsburgh (Family Success Network)

Not yet recruiting
  • Maltreatment by Parent
  • Family Success Network
  • Cleveland, Ohio
  • +2 more
Nov 17, 2023

Atrial Fibrillation Recurrence Trial in Ramat Gan (CardiaCareTM RR2)

Completed
  • Atrial Fibrillation Recurrence
  • CardiaCareTM RR2
  • Ramat Gan, Israel
    Sheba medical center
Feb 21, 2022

Acute Lymphoblastic Leukemia Trial (chidamide, Venetoclax Oral Tablet, Inotuzumab Ozogamicin)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • (no location specified)
Oct 19, 2023

Follicular Lymphoma, Relapsed and Refractory Follicular Lymphoma Trial in Guangzhou (Orelabrutinib and Rituximab, Orelabrutinib)

Recruiting
  • Follicular Lymphoma
  • Relapsed and Refractory Follicular Lymphoma
  • Guangzhou, Guangdong, China
  • +2 more
Mar 23, 2022

RR DLBCL; PD-1; CD20 Trial (F520+F007)

Not yet recruiting
  • RR DLBCL; PD-1; CD20
  • (no location specified)
Dec 17, 2021

Asthma COPD Trial in Birmingham (Wheeze measurement)

Recruiting
  • Asthma COPD
  • Wheeze measurement
  • Birmingham, West Midlands, United Kingdom
    University Hospitals Birmingham NHS Foundation Trust
Sep 14, 2023

Sleep and Mood Quality Trial in India (VL-NL-02, Placebo)

Not yet recruiting
  • Sleep and Mood Quality
  • VL-NL-02
  • Placebo
  • Dombivli, Maharashtra, India
  • +4 more
Sep 20, 2023

Tuberculosis, Multidrug-Resistant Trial (Amikacin)

Not yet recruiting
  • Tuberculosis, Multidrug-Resistant
  • (no location specified)
Sep 23, 2022

Multiple Myeloma Trial in Xuzhou (anti-BCMA/GPRC5D CAR-T CELL)

Recruiting
  • Multiple Myeloma
  • anti-BCMA/GPRC5D CAR-T CELL
  • Xuzhou, Jiangsu, China
    Kailin Xu
Aug 19, 2022

Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis Trial in Port Elizabeth (Bedaquiline Oral Tablet, Linezolid

Active, not recruiting
  • Tuberculosis
  • +4 more
  • Bedaquiline Oral Tablet
  • +7 more
  • Port Elizabeth, Eastern Cape, South Africa
  • +1 more
Oct 20, 2022

Diffuse Large B-cell Lymphoma Trial in Hangzhou, Ningbo (CD19-7×19 CAR-T combined with Tislelizumab)

Recruiting
  • Diffuse Large B-cell Lymphoma
  • CD19-7×19 CAR-T combined with Tislelizumab
  • Hangzhou, Zhejiang, China
  • +1 more
Dec 12, 2022

Acute Asthma Trial in Detroit (arformoterol (RR formoterol), , levalbuterol)

Terminated
Has Results
  • Acute Asthma
  • arformoterol (RR formoterol)
  • +2 more
  • Detroit, Michigan
    Henry Ford Hospital Emergency Department
Jan 6, 2023

Autism Spectrum Disorder, Neurodevelopmental Disorders Trial in Rochester, Philadelphia, Seattle (Remaking Recess (RR))

Recruiting
  • Autism Spectrum Disorder
  • Neurodevelopmental Disorders
  • Remaking Recess (RR)
  • Rochester, New York
  • +2 more
Oct 8, 2021

Pneumonia, Bacterial, Respiratory Failure, COVID-19 Pneumonia Trial in Moscow (Arterial blood gases, Respiratory rate (RR),

Recruiting
  • Pneumonia, Bacterial
  • +2 more
  • Arterial blood gases
  • +7 more
  • Moscow, Russian Federation
    City clinical hospital named after F.I.Inozemtsev, Moscow
Nov 2, 2023

Relapsed or Refractory DLBCL Trial in United States (Selinexor, Rituximab, Bendamustine)

Suspended
  • Relapsed or Refractory Diffuse Large B-Cell Lymphoma
  • Tucson, Arizona
  • +17 more
Jan 24, 2023

Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in China (ATG-010 and ATG-008)

Recruiting
  • Relapsed/Refractory Diffuse Large B-cell Lymphoma
  • ATG-010 and ATG-008
  • Chongqing, Chongqing, China
  • +5 more
Sep 2, 2022

Multiple Sclerosis, Relapsing-Remitting Trial in Chisinau (IMCY-0141, Placebo, Dimethyl Fumarate)

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Chisinau, Moldova, Republic of
    Republican Clinical Hospital, ARENSIA Exploratory Medicine
Jun 8, 2022

Retentive Strength of Denture Adhesives Trial in Karachi (polymyxin b/trimethoprim ophthalmic, Carboxymethyl cellulose)

Recruiting
  • Retentive Strength of Denture Adhesives
  • polymyxin b/trimethoprim ophthalmic, Carboxymethyl cellulose
  • Karachi, Sindh, Pakistan
    Altamash Institute of dental medicine
Sep 21, 2021

Covid19 Trial in Marseille, Hyères, Toulon (Respiratory rehabilitation program (RR)., Respiratory tele-rehabilitation program

Completed
  • Covid19
  • Respiratory rehabilitation program (RR).
  • Respiratory tele-rehabilitation program (TRR).
  • Marseille, Bouches Du Rhône, France
  • +2 more
Feb 1, 2022

Face-masks, Exercise Trial (Spirometry - baseline, Spirometry - post CPET, Nasal peak inspiratory flow - baseline)

Not yet recruiting
  • Face-masks
  • Exercise
  • Spirometry - baseline
  • +11 more
  • (no location specified)
Jan 1, 2022